Search results
Results From The WOW.Com Content Network
Drug Delivery is a peer-reviewed open access medical journal covering research on all aspects of drug delivery, a core aspect of drug development. It is published by Taylor & Francis and since 2009 the editor-in-chief is Vladimir Torchilin. Biochemist Alfred Stracher founded the journal in 1997 and was its editor-in-chief until his death in ...
Drug Delivery; Drug Design, Development and Therapy; Drug Development and Industrial Pharmacy; Drug Discovery Today; Drug, Healthcare and Patient Safety; Drug Safety; Drug Metabolism Reviews; Drug Testing and Analysis; European Heart Journal - Cardiovascular Pharmacotherapy; European Journal of Pharmaceutical Sciences; European Journal of ...
Expert Opinion on Drug Delivery is a monthly peer-reviewed medical journal publishing review articles covering all aspects of research on drug delivery, from initial concept to potential therapeutic application and final relevance in clinical use. It was established in 2004 and is published by Taylor and Francis Group.
Advanced Drug Delivery Reviews is a peer-reviewed medical journal covering research involving the controlled release and delivery of drugs and other biologically active agents. [ 1 ] The editor-in-chief is H. Ghandehari.
First published in 2004 by the American Chemical Society, it is considered one of the most prestigious journals in the field of pharmaceutics, physical pharmacy and drug delivery. Its publication frequency switched from bimonthly to monthly in 2012. According to the Journal Citation Reports, the journal has a 2021 impact factor of 5.364. [1]
Drug design: Informa: English: 1997–present Expert Review of Clinical Pharmacology: Clinical pharmacology: Informa: English: 2008–present Expert Review of Respiratory Medicine: Pulmonary: Taylor & Francis: English: 2007–present Family Practice (journal) Family medicine: Oxford University Press: English: 1984–present Foot and Ankle ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The four journals cover developments across the breadth of therapeutic areas and technologies relevant to the drug discovery and development pipeline. However, as of 2022, these titles have been discontinued and incorporated back into Drug Discovery Today. According to the Journal Citation Reports, the journal has a 2022 impact factor of 8.2. [1]